Adenocarcinoma of the cervix and Acute bilateral obstructive uropathy

Summary:

Acute bilateral obstructive uropathy is reported only by a few people with Adenocarcinoma of the cervix.

The study analyzes which people have Acute bilateral obstructive uropathy with Adenocarcinoma of the cervix. It is created by eHealthMe based on 2 people who have Acute bilateral obstructive uropathy and Adenocarcinoma of the cervix from the Food and Drug Administration (FDA), and is updated regularly.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.



On Nov, 30, 2022

2 people who have Adenocarcinoma Of The Cervix and Acute Bilateral Obstructive Uropathy are studied.


What is Adenocarcinoma of the cervix?

Adenocarcinoma of the cervix (cervical cancer) is found to be associated with 105 drugs and 49 conditions by eHealthMe.

What is Acute bilateral obstructive uropathy?

Acute bilateral obstructive uropathy (sudden blockage of the flow of urine from both kidneys) is found to be associated with 625 drugs and 349 conditions by eHealthMe.

Number of Acute bilateral obstructive uropathy in Adenocarcinoma of the cervix reports submitted per year:

Would you have Acute bilateral obstructive uropathy when you have Adenocarcinoma of the cervix?

Gender of people who have Adenocarcinoma Of The Cervix and experienced Acute Bilateral Obstructive Uropathy *:

  • female: 100 %
  • male: 0.0 %

Age of people who have Adenocarcinoma Of The Cervix and experienced Acute Bilateral Obstructive Uropathy *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 100 %
  • 50-59: 0.0 %
  • 60+: 0.0 %

Common drugs taken by these people *:

  1. Erbitux: 2 people, 100.00%
  2. Cisplatin: 2 people, 100.00%

Common symptoms for these people *:

  1. Blood Creatinine Increased: 2 people, 100.00%
  2. Haemoglobin Decreased: 1 person, 50.00%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Acute bilateral obstructive uropathy?

Check whether Acute bilateral obstructive uropathy is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related studies

Treatments, associated drugs and conditions:

COVID vaccines that are related to Acute bilateral obstructive uropathy:

All the drugs that are associated with Acute bilateral obstructive uropathy:

All the conditions that are associated with Acute bilateral obstructive uropathy:

How the study uses the data?

The study is based on Acute bilateral obstructive uropathy and Adenocarcinoma of the cervix, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: